Workplace Testing Terms tagged with 'Drug Testing'
- Background Check
- Sensitive Information
- Presenteeism
- Hazard Identification Study (HAZID)
- Immunoassay Screening
- Aliquot
- Random Drug Testing
- Intoxication
- Laboratory Testing
- Employee Assistance Program (EAP)
- Alcohol Testing
- Gas Chromatography Mass Spectrometry (GC-MS)
- Culture of Health
- Preferred Employee Assistance Program (EAP)
- Workplace Testing
- Urine Testing
- Driver’s License Abstract
- Alcohol Testing Site
- Reasonable Suspicion
- Oral Fluid Testing
- Air Blank
- Prohibited Controlled Substances
- Refusal to Test
- Confirmatory Validity Test
- Collection Container
- Clinic
- Stand-Down
- Split Specimen Collection
- Continuing Education
- Buffer
- Blind Performance Test Specimen
- Binding
- Detoxification
- Clinical Laboratory Improvement Amendments Waived (CLIA)
- 5-Panel Drug Test
- Substance Abuse Professional (SAP)
- Controlled Substance
- Confirmatory Drug Test
- Drug Testing
- Preferred Provider Organization (PPO)
- Conditional Job Offer
- Driving While Intoxicated (DWI)
- Ethyl Sulfate (EtS)
- Collector
- Confirmation Test
- Ecstasy (MDMA)
- Diluted Specimen
- Service Agent
- Shipping Container
- Urine Point of Collection Test (Urine POCT)
- Department of Transportation Test
- Alcohol Confirmation Test
- Accession Number
- Calibration
- Calibration Check
- Phencyclidine (PCP)
- Positive Test Result
- Temperature Strip
- Department of Transportation (DOT)
- No Probable Cause
- Driving Under the Influence (DUI)
- Laboratory
- Society for Human Resource Management (SHRM)
- Qualitative
- Probable Cause Drug Testing
- Normal Result
- Antibody
- Carrier
- Instant Test Kit
- Illicit Drugs
- Drug Metabolites
- Follow-Up Testing
- Alcohol Use
- Agglutination
- Saliva
- Mobile Phase
- Zero Tolerance
- Initial Validity Test
- Immunoglobulin
- Absorption
- Initial Drug Screen
- Immunogenicity
- Immunogen
- Epitope
- Metabolite
- Point of Care Test (POCT)
- Gas Chromatography
- Retention Time
- Opiate
- National Institute on Drug Abuse (NIDA)
- Reasonable Suspicion Testing
- Controlled Drugs and Substances Act (CDSA)
- Assay
- Reconfirmed
- Limit of Quantitation
- Scheduled Testing
- Therapeutic Range
- Therapeutic Drug Monitoring (TDM)
- Accident
- Antigen
- Target Drug
- National Association of Drug Court Professionals (NADCP)
- Fluorescence
- Screening Drug Test
- Post-Incident Testing
- Enzyme Multiplied Immunoassay Technology (EMIT)
- Enzyme-Labeling
- Synthetic Cannabinoid
- False Positive
- International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
- International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- Random Testing
- Reasonable Cause Testing
- Return to Duty Testing (RTD)
- Comparative Analysis
- Drugs of Abuse Testing (DAT)
- Designated Employer Representative (DER)
- American Society of Safety Engineers (ASSE)
- Limit of Detection (LOD)
- Mass Spectrometry
- Invalid Drug Test
- Workplace Drug and Alcohol Policy
- High Performance Liquid Chromatography - Mass Spectrometry and Liquid Chromatography (HPLC / MS)
- Office of Drug and Alcohol Policy and Compliance (ODAPC)
- Benzodiazepines
- Negative Result
- Drugs and Alcohol Testing Industry Association (DATIA)
- Breath Alcohol Technician (BAT)
- Collection Site
- Express to Lab Testing
- Forensic Use Only
- Certification Testing
- Medical Review Officer Assistant (MROA)
- Evidential Breath Testing Device
- Chain of Custody (CoC)
- Applicant Tracking System (ATS)
- Verified Test
- Enzyme
- Screening Test Technician (STT)
- Calibrator
- Synthetic Opioids
- Standard Error of the Estimate (SSE)
- Oral Fluid
- Recovery Study
- Immunoassay Screening Test
- Health and Human Services
- Department of Health and Human Services (HHS)
- Creatine
- Qualification Training
- Rejected for Testing
- Refresher Training
- Incident
- Drugs
- Suspension
- Scattergram
- Receptor
- Reagent
- National On-Site Testing Association (NOTA)
- Substrate
- Stationary Phase
- Mediation
- Cutoff
- Cross-Reactivity
- Control
- Consortium/Third-Party Administrator (C/TPA)
- Driver
- Under the Influence of Intoxicating Liquor or Drugs
- Validation Testing
- Hair Follicle Drug Testing
- Program Administrator (PA)
- Amino Acid
- Commercial Motor Vehicle
- Investigative Consumer Report
- Positive Drug Testing Result
- Negative Drug Test Result
- Initial Validity Drug Test
- Initial Drug Test
- Confirmation Validity Test
- Misdemeanor
- Immune System
- B Sample
- Split Specimen
- Addiction
- Addict
- Amphetamine
- 10 Panel Drug Test
- A Sample
- Negative Dilute Drug Test Result
- Positive Dilute Drug Test Result
- Doping Control
- Registered Testing Pool (RTP)
- Blood Collection Officer (BCO)
- With-Cause Evaluation
- Cannabis
- Fitness for Duty (FFD)
- Accuracy Check
- Invalid Test Result
- Verified Laboratory Test
- Buffering Capacity
- Dopamine
- Drug Enforcement Agency (DEA)
- Methadone
- In-Competition Testing
- Out-of-Competition Testing
- Antihistamines
- Withdrawal
- Parts Per Million (PPM)
- Cocaine
- Partial Sample
- Masking Agent
- Banned Substance
- Fentanyl
- Transdermal
- Androstenedione
- Trade Name
- Morphine Patch
- Nicotine Patch
- Coca
- Dependence
- Barbiturate
- Chronic Pain
- Assertive Community Treatment (ACT)
- Non Cross-Reacting Compound
- Antipsychotic
- Recovery
- THC
- Breath Alcohol Content (BrAC)
- Hallucinogen
- Coke Bugs
- Narcotic
- Buprenorphine
- Constricted Pupils
- Substance Dependence
- Paranoia
- Cannabinoid
- Craving
- Prescription Drug
- High
- Fix
- Prodrug
- Bath Salts
- Methamphetamine
- Adulterated Specimen
- Lysergic Acid Diethylamide (LSD)
- False Negative
- Dronabinol
- Adulterate
- Substance Abuse
- Paraphernalia
- Downer
- Track Marks
- Relapse
- Blackout
- Overdose
- Methaqualone
- Opioid
- Heroin
- Substance Abuse Treatment Program
- Schedule I
- Schedule II
- Schedule III
- Hallucination
- Diuretics
- Medical Review Officer (MRO)
- Therapeutic Use Exemption (TUE)
- Photometer
- Hydrocodone
- Oxycodone
- 49 CFR Part 40
- Substance Abuse Evaluation
- Radiant Energy
- Cancelled test
- Third-Party Administrator (TPA)
- Synthetic Urine
- 9 Panel Drug Test
- 12 Panel Drug Test
- 15 Panel Drug Test
- Plasma
- Polypeptides
- Immunochemical
- Absorbance
- Hapten
- Response Time
- Phagocytosis
- Antigenicity
- SAMHSA Certified Lab
- Blind Sample Testing
- Target Cell
- Coefficient of Variation
- Molecular Weight
- Myeloma
- Immunize
- Leukocytes
- Monitored Collection
- Observed Testing
- 4-Panel Drug Test
- 7-Panel Drug Test
- 8-Panel Drug Test
- Pulmonary Function Test
- Pre-Access Testing
- Pre-Employment Drug Testing
- Substance Abuse & Mental Health Services Administration (SAMHSA)
- The International Association of Forensic Toxicologists (TIAFT)
- Primary Specimen
- Portable Breath Tester (PBT)
- Substituted Specimen
- Recovery Time
- Point-of-Collection Test
- Quality Assurance Plan (QAP)
- Non-Negative Specimen
- Cognitive Decline
- Wet Bath
- Gold Standard
- Absence Rate
- Neurotransmitter
- Diversion Program
- Associated General Contractors of America (AGC)
- Alternative Medicine
- Hallucinogens
- Deferred Adjudication
- Commercial Driver's License (CDL)
- Negative Dilute
- Suspended Sentence
- Drug Paraphernalia
- Federal Aviation Administration (FAA)
- United States Coast Guard (USCG)
- Federal Transit Administration (FTA)
- Federal Railroad Administration (FRA)
- Pipeline & Hazardous Materials Safety Administration (PHMSA)
- Drug and Alcohol Clearinghouse
- Liquid Chromatography
- Specimen
- Medical Examination